Carcinogenicities of quinoline derivatives in F344 rats. 1981

S Fukushima, and Y Ishihara, and O Nishio, and T Ogiso, and T Shirai, and N Ito

In Ames test, the quinoline derivatives, 6-nitroquinoline (6-NQ), 8-nitroquinoline (8-NQ), 6-methylquinoline (6-NQ), 8-methylquinoline (8-MQ) and 8-hydroxyquinoline (8-HQ) are mutagenic, whereas 5,7-dibromo-quinoline (5,7-DQ) is not. These compounds were administered to groups of male and female F344 rats in their diet for 104 weeks. 8-NQ induced forestomach tumors in male and female rats: it induced squamous cell papillomas in 28 (93.3%) of 30 males and in 36 (97.3%) of 37 females, and squamous cell carcinomas in 20 (66.7%) of 30 males and 24 (64.9%) of 37 females. Thus there was no sex difference in its carcinogenicity. 6-NQ induced only focal hyperplasia of the forestomach at an incidence of 30.0% in male rats and 52.8% in female rats. These results indicate a discrepancy between the mutagenicities of quinoline derivatives and their carcinogenicities to rats: only 8-NQ was carcinogenic to F344 rats.

UI MeSH Term Description Entries
D006965 Hyperplasia An increase in the number of cells in a tissue or organ without tumor formation. It differs from HYPERTROPHY, which is an increase in bulk without an increase in the number of cells. Hyperplasias
D008297 Male Males
D009152 Mutagenicity Tests Tests of chemical substances and physical agents for mutagenic potential. They include microbial, insect, mammalian cell, and whole animal tests. Genetic Toxicity Tests,Genotoxicity Tests,Mutagen Screening,Tests, Genetic Toxicity,Toxicity Tests, Genetic,Genetic Toxicity Test,Genotoxicity Test,Mutagen Screenings,Mutagenicity Test,Screening, Mutagen,Screenings, Mutagen,Test, Genotoxicity,Tests, Genotoxicity,Toxicity Test, Genetic
D009374 Neoplasms, Experimental Experimentally induced new abnormal growth of TISSUES in animals to provide models for studying human neoplasms. Experimental Neoplasms,Experimental Neoplasm,Neoplasm, Experimental
D010212 Papilloma A circumscribed benign epithelial tumor projecting from the surrounding surface; more precisely, a benign epithelial neoplasm consisting of villous or arborescent outgrowths of fibrovascular stroma covered by neoplastic cells. (Stedman, 25th ed) Papilloma, Squamous Cell,Papillomatosis,Papillomas,Papillomas, Squamous Cell,Papillomatoses,Squamous Cell Papilloma,Squamous Cell Papillomas
D011804 Quinolines
D011916 Rats, Inbred F344 An inbred strain of rat that is used for general BIOMEDICAL RESEARCH purposes. Fischer Rats,Rats, Inbred CDF,Rats, Inbred Fischer 344,Rats, F344,Rats, Inbred Fisher 344,CDF Rat, Inbred,CDF Rats, Inbred,F344 Rat,F344 Rat, Inbred,F344 Rats,F344 Rats, Inbred,Inbred CDF Rat,Inbred CDF Rats,Inbred F344 Rat,Inbred F344 Rats,Rat, F344,Rat, Inbred CDF,Rat, Inbred F344,Rats, Fischer
D001743 Urinary Bladder A musculomembranous sac along the URINARY TRACT. URINE flows from the KIDNEYS into the bladder via the ureters (URETER), and is held there until URINATION. Bladder,Bladder Detrusor Muscle,Detrusor Urinae,Bladder Detrusor Muscles,Bladder, Urinary,Detrusor Muscle, Bladder,Detrusor Muscles, Bladder
D001835 Body Weight The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms. Body Weights,Weight, Body,Weights, Body
D002273 Carcinogens Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. Carcinogen,Oncogen,Oncogens,Tumor Initiator,Tumor Initiators,Tumor Promoter,Tumor Promoters,Initiator, Tumor,Initiators, Tumor,Promoter, Tumor,Promoters, Tumor

Related Publications

S Fukushima, and Y Ishihara, and O Nishio, and T Ogiso, and T Shirai, and N Ito
April 1995, Fundamental and applied toxicology : official journal of the Society of Toxicology,
S Fukushima, and Y Ishihara, and O Nishio, and T Ogiso, and T Shirai, and N Ito
June 1976, Research communications in chemical pathology and pharmacology,
S Fukushima, and Y Ishihara, and O Nishio, and T Ogiso, and T Shirai, and N Ito
May 1983, Journal of the National Cancer Institute,
S Fukushima, and Y Ishihara, and O Nishio, and T Ogiso, and T Shirai, and N Ito
September 1968, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
S Fukushima, and Y Ishihara, and O Nishio, and T Ogiso, and T Shirai, and N Ito
January 1985, Princess Takamatsu symposia,
S Fukushima, and Y Ishihara, and O Nishio, and T Ogiso, and T Shirai, and N Ito
December 1962, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
S Fukushima, and Y Ishihara, and O Nishio, and T Ogiso, and T Shirai, and N Ito
March 1966, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
S Fukushima, and Y Ishihara, and O Nishio, and T Ogiso, and T Shirai, and N Ito
April 1964, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
S Fukushima, and Y Ishihara, and O Nishio, and T Ogiso, and T Shirai, and N Ito
October 1963, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
S Fukushima, and Y Ishihara, and O Nishio, and T Ogiso, and T Shirai, and N Ito
July 1962, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
Copied contents to your clipboard!